Yuanzhi Lu

Jinan University — China

Medicine · Health Sciences

15h-index1.0kcitations61works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(11), Cancer-related Molecular Pathways(9), Hedgehog Signaling Pathway Studies(9), RNA modifications and cancer(8), Cancer Immunotherapy and Biomarkers(7)

Publications54 total

Mechanistic insights into the photodegradation of cyclotriphosphazene flame retardants from computational and experimental evidence
Journal of Hazardous Materials·2026
Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review
World Journal of Surgical Oncology·2025Open Access
Unveiling photodegradation mechanisms of short-chain chlorinated paraffins via integrated experimental and computational chemistry
Journal of Hazardous Materials·2025
Correlation between ADGRV1 expression and clinical pathological and prognostic features in breast cancer
Scientific Reports·2025Open Access
Immunomodulatory hydrogel loaded with PD-L1-expressing exosomes reprograms macrophages and accelerates diabetic wound healing
Biomaterials Advances·2025· 4 cited
Predictive role of HPGD gene in carcinogenesis and immune environment monitoring in human cervical cancer
Cancer Biomarkers·2024· 2 citedOpen Access
P2.11A.23 Fecal Microbiota Transplantation Plus Rechallenging Immunotherapy in Patients with Advanced Non Small Cell Lung Cancer: An Exploratory Study
Journal of Thoracic Oncology·2024· 1 citedOpen Access
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
Cancer·2024· 9 citedOpen Access
[Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy].
PubMed·2024Open Access
Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Molecular Cancer·2024· 11 citedOpen Access
Clinicopathological Characteristics of 11 Cases with Spiradenoma: A Rare Adnexal Tumor
American Journal of Clinical and Experimental Medicine·2024Open Access
Fertility-Sparing Surgery and Adjuvant Chemotherapy with Trastuzumab Result in Complete Remission in a Young Woman with Rare Primary Mucinous Ovarian Cancer due to ERBB2 Co-amplification with CDK12 and Chromosome 11q13.3 Amplicon: A Case Report and Literature Review
Reproductive Sciences·2024· 2 cited
Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
Annals of Medicine·2023· 8 citedOpen Access
Expert consensus on the diagnosis and treatment of <scp>RET</scp> gene fusion <scp>non‐small</scp> cell lung cancer in <scp>China</scp>
Thoracic Cancer·2023· 12 citedOpen Access
Bioinformatics-based screening of key genes for transformation of tyrosine kinase inhibitor-resistant lung adenocarcinoma to small cell lung cancer
Frontiers in Medicine·2023· 2 citedOpen Access
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer
World Journal of Surgical Oncology·2023· 10 citedOpen Access
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type
Applied immunohistochemistry & molecular morphology·2023· 5 citedOpen Access
Malignant Struma Ovarii (Papillary Carcinoma) with Hyperthyroidism: A Case Report and Literature Review
Case Reports in Oncology·2023· 4 citedOpen Access
Experimental assessment of robust reference genes for qRT-PCR in lung cancer studies
Frontiers in Oncology·2023· 2 citedOpen Access
Supplementary Methods, Tables 1-2, Figures 1-4 from Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Sarmila Majumder(11), Bhuvaneswari Ramaswamy(7), Charles L. Shapiro(7), Kun‐Yu Teng(6), Wenxian Wang(5), Ting Huang(5), Xiaobai Li(4), Samson T. Jacob(4), Qingzheng Zhao(4), C. Xu(4), Zhengbo Song(4), Yongchang Zhang(4), Hongbing Liu(4), Tangfeng Lv(4), Liyun Miao(4), You‐cai Zhu(4), Biyun Lin(4), Renyu Zhou(4), Gerard J. Nuovo(3), Satavisha Roy(3)